Literature DB >> 21573702

PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Kwang Youl Lee1, Jeong Woon Lee, Hyun Jeong Nam, Jeong-Hyun Shim, Youngsup Song, Keon Wook Kang.   

Abstract

Acquired resistance to tamoxifen (TAM) is a serious therapeutic problem in breast cancer patients. We have shown that Pin1, a peptidyl prolyl isomerase, is consistently overexpressed in TAM-resistant MCF-7 cells (TAMR-MCF-7 cells) and plays a key role in the enhanced angiogenic potential of TAMR-MCF-7 cells. In the present study, we focused on signaling pathways for Pin1 up-regulation in TAMR-MCF-7 cells. Relative to MCF-7 cells, Pin1 gene transcription and E2 transcription factor1 (E2F1) expression were enhanced in TAMR-MCF-7 cells. E2F1 siRNA significantly reduced both the protein expression and the promoter transcriptional activity of Pin1. Activities of phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase (ERK) and p38 kinase were all higher in TAMR-MCF-7 cells than in control MCF-7 cells and the enhanced Pin1 and E2F1 expression in TAMR-MCF-7 cells was reversed by inhibition of PI3K or p38 kinase. Moreover, the higher production of vascular endothelial growth factor (VEGF) in TAMR-MCF-7 cells was significantly diminished by suppression of PI3K or p38 kinase. These results suggest that Pin1 overexpression and subsequent VEGF production in TAMR-MCF-7 cells are mediated through PI3-kinase or p38 kinase-dependent E2F1 activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21573702      PMCID: PMC3887657          DOI: 10.1007/s10059-011-0074-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  31 in total

1.  Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding.

Authors:  Elena Bayer; Sandra Goettsch; Jonathan W Mueller; Bernhard Griewel; Elena Guiberman; Lorenz M Mayr; Peter Bayer
Journal:  J Biol Chem       Date:  2003-04-29       Impact factor: 5.157

Review 2.  E2F target genes: unraveling the biology.

Authors:  Adrian P Bracken; Marco Ciro; Andrea Cocito; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2004-08       Impact factor: 13.807

3.  Expression of Pin1, a peptidyl-prolyl isomerase, in the ovaries of eCG/hCG-treated immature female mice.

Authors:  Takashi Shimizu; Hirotada Akiyama; Yasuyuki Abe; Hiroshi Sasada; Eimei Sato; Akio Miyamoto; Takafumi Uchida
Journal:  J Reprod Dev       Date:  2005-12-28       Impact factor: 2.214

4.  Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.

Authors:  J A Pulikkan; V Dengler; A A Peer Zada; A Kawasaki; M Geletu; Z Pasalic; S K Bohlander; A Ryo; D G Tenen; G Behre
Journal:  Leukemia       Date:  2010-04-08       Impact factor: 11.528

5.  Transcriptional regulation of AKT activation by E2F.

Authors:  Marie Chaussepied; Doron Ginsberg
Journal:  Mol Cell       Date:  2004-12-03       Impact factor: 17.970

Review 6.  Pinning down cell signaling, cancer and Alzheimer's disease.

Authors:  Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2004-04       Impact factor: 13.807

7.  Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.

Authors:  Gerburg Wulf; Priti Garg; Yih-Cherng Liou; Dirk Iglehart; Kun Ping Lu
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

8.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 9.  Estrogen receptors: new perspectives in breast cancer management.

Authors:  E Petrangeli; C Lubrano; F Ortolani; L Ravenna; A Vacca; S Sciacchitano; L Frati; A Gulino
Journal:  J Steroid Biochem Mol Biol       Date:  1994-06       Impact factor: 4.292

10.  Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.

Authors:  C Rose; S M Thorpe; K W Andersen; B V Pedersen; H T Mouridsen; M Blichert-Toft; B B Rasmussen
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

View more
  18 in total

1.  B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells.

Authors:  Frank Secreto; Michelle Manske; Tammy Price-Troska; Steven Ziesmer; Lucy S Hodge; Stephen M Ansell; James R Cerhan; Anne J Novak
Journal:  Leuk Lymphoma       Date:  2014-02-24

2.  Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Authors:  Sung Hwan Ki; Jung-Woon Lee; Sung Chul Lim; Tran Thi Hien; Ji Hye Im; Won Keun Oh; Moo Yeol Lee; Young Hyun Ji; Yoon Gyoon Kim; Keon Wook Kang
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 3.  Prolyl isomerase Pin1 in cancer.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Res       Date:  2014-08-15       Impact factor: 25.617

4.  An Ω-3 fatty acid desaturase-expressing gene attenuates prostate cancer proliferation by cell cycle regulation.

Authors:  Jinshun Pan; Sujin Zhou; Rong Xiang; Zhenggang Zhao; Shanshan Liu; Ning Ding; Sijia Gong; Yan Lin; Xiaoxi Li; Xiaoming Bai; Fanghong Li; Allan Z Zhao
Journal:  Oncol Lett       Date:  2017-03-21       Impact factor: 2.967

5.  E2F activators signal and maintain centrosome amplification in breast cancer cells.

Authors:  Mi-Young Lee; Carlos S Moreno; Harold I Saavedra
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

Review 6.  PIN1 in breast development and cancer: a clinical perspective.

Authors:  Alessandra Rustighi; Alessandro Zannini; Elena Campaner; Yari Ciani; Silvano Piazza; Giannino Del Sal
Journal:  Cell Death Differ       Date:  2016-11-11       Impact factor: 15.828

7.  Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

Authors:  Yohei Narita; Takayuki Murata; Akihide Ryo; Daisuke Kawashima; Atsuko Sugimoto; Teru Kanda; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice.

Authors:  Chengwen Liu; Weiyi Peng; Chunyu Xu; Yanyan Lou; Minying Zhang; Jennifer A Wargo; Jie Qing Chen; Haiyan S Li; Stephanie S Watowich; Yan Yang; Dennie Tompers Frederick; Zachary A Cooper; Rina M Mbofung; Mayra Whittington; Keith T Flaherty; Scott E Woodman; Michael A Davies; Laszlo G Radvanyi; Willem W Overwijk; Gregory Lizée; Patrick Hwu
Journal:  Clin Cancer Res       Date:  2012-11-30       Impact factor: 12.531

9.  The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.

Authors:  Anamitra Ghosh; Hariharan Saminathan; Arthi Kanthasamy; Vellareddy Anantharam; Huajun Jin; Gautam Sondarva; Dilshan S Harischandra; Ziqing Qian; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

10.  Ubiquilin 1 interacts with Orai1 to regulate calcium mobilization.

Authors:  Jeong-Eun Lee; In-Sook Jeon; Na-Eun Han; Hye-Jin Song; Eung-Gook Kim; Jae-Woon Choi; Ki-Duk Song; Hak-Kyo Lee; Joong-Kook Choi
Journal:  Mol Cells       Date:  2013-01-09       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.